Fabulous talk by @wolchokj right now during #AACRtii21! Checkout the group's latest work in this @CIR_AACR paper on #biomarkers of response to #nivolumab and #ipilimumab in patients with advanced #melanoma. https://t.co/VuYeTZJBLR
RT @humanimmunenews: Combined assessment of tumor mutational burden, #inflammatory gene expression signature, and BRAF mutation status may…
RT @humanimmunenews: Combined assessment of tumor mutational burden, #inflammatory gene expression signature, and BRAF mutation status may…
Combined assessment of tumor mutational burden, #inflammatory gene expression signature, and BRAF mutation status may be predictive for response to #immune checkpoint blockade in advanced melanoma. @CIR_AACR: https://t.co/lQlziweBCU https://t.co/MsqcclOsQ
TMB and Inflammatory Gene Expression Associated With Clinical Outcomes Following Immunotherapy in Advanced Melanoma. https://t.co/XjD175JfP9 https://t.co/JIlDTMTIsh
TMB and Inflammatory Gene Expression Associated With Clinical Outcomes Following Immunotherapy in Advanced Melanoma https://t.co/i8vwJUpFaL https://t.co/wsEspc9ci9
New article: TMB and Inflammatory Gene Expression Associated With Clinical Outcomes Following Immunotherapy in Advanced Melanoma https://t.co/kTRqqoiUEw #melanoma #oncology https://t.co/uEh6mNnWah